NCT06867900View on ClinicalTrials.gov

Unexplained Recurrent Pregnancy Loss: New Therapeutic Perspectives

NAActive, not recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

July 5, 2023

Study Completion Date

July 6, 2025

Conditions
Miscarriage, Recurrent
Interventions
DIETARY_SUPPLEMENT

Bifidobacterium Longum ES1

Oral administration of Bifidobacterium Longum ES1 for three months.

Trial Locations (1)

00168

Reasearch Laboratory 3J IRCCS Gemelli, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER